Chemical Intermediate Hbt1 Powder CAS 489408-02-8 Nootropics Supplements Ydl223c Hbt1

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: API
• Certification: GMP, ISO 9001
• Suitable for: All
• State: Solid
• Purity: >99%
• Keyword: Hbt1
• Sample: Available
• MOQ: Consult
• Mf: C16h17f3n4o2s
• CAS: 489408-02-8
• Test Method: HPLC
• Transport Package: Aluminum Foil Bag/Paper Drum
• Specification: 99%
• Trademark: xinlu
• Origin: China
• Production Capacity: 100kg

Product Description

 

HBT1 is a potent and selective α-Amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptor potentiator. It acts by enhancing the function of AMPA receptors, which are a type of glutamate receptor found in the brain. HBT1 binds to a specific site on the AMPA receptor, known as the S518 residue in the ligand-binding domain (LBD), in a glutamate-dependent manner. This binding leads to an increase in the activity of the AMPA receptor, resulting in enhanced synaptic transmission and potentially improved cognitive function.

 

Product name:	HBT1
Appearance:	Whte powder
CAS:	489408-02-8
Purity:	99%
Grade Standard:	Medicine Grade

 

1. AMPA Receptor Potentiation: HBT1 functions as an AMPA receptor potentiator, enhancing the activity of these receptors and increasing synaptic transmission in the brain.
2. Neuroprotection: By potentiating AMPA receptors, HBT1 may have neuroprotective effects, protecting neurons from damage caused by excitotoxicity and oxidative stress.
3. Cognitive Enhancement: Enhanced AMPA receptor activity is associated with improved cognitive function, including memory, learning, and attention. Therefore, HBT1 may have potential applications in the treatment of cognitive impairments.

 

1. Neuroscience Research: HBT1 is used in neuroscience research to investigate the role of AMPA receptors in cognitive processes such as memory, learning, and synaptic plasticity.
2. Pharmaceutical Development: It has potential applications in the development of new therapeutic agents for the treatment of cognitive impairments associated with neurological disorders such as Alzheimer's disease, Parkinson's disease, and stroke.
3. In Vitro Studies: HBT1 is also used in in vitro studies to assess its effects on brain-derived neurotrophic factor (BDNF) production and neuronal growth.

Related products

Product Name	CAS No.	Product Name	CAS No.
Lufenuron	103055-07-8	Toltrazuril	69004-03-1
Nitenpyram	120738-89-8	Praziquantel/Biltricide	55268-74-1
Fenbendazole	43210-67-9	Tetramisole Hcl	5086-74-8
Levamisole	14769-73-4	Ponazuril	9004-4-2
Diclazuril	101831-37-2	Florfenicol	73231-34-2
Albendazole	54965-21-8	Mebendazole	31431-39-7
Ivermectin	70288-86-7	Enrofloxacin Hcl	112732-17-9
RU 58841	154992-24-2	cb-03-01	19608-29-8
Biotin	58-85-5	Biotinoyl tripeptide-1	299157-54-3
Finasteride	98319-26-7	Dutasteride	164656-23-9

Xi'an Xinlu Biotechnology Co., Ltd. is a high-end brand company focusing on the biomedical industry and integrating R&D, production and sales.  It has an independent R&D center, advanced laboratory equipment and a professional R&D team, a GMP standard production workshop, a complete set of internationally advanced assembly line equipment, a preparation workshop with a cleanliness level of 100,000, as well as sophisticated testing instruments and scientific testing methods, providing solid technical support for the production of high-quality products.  Through long-term R&D, production, and sales practices, it has formed its own unique product line, providing users with products of reliable quality at highly affordable prices.  We strictly control quality, ensure the stability of product quality in all aspects, and win the trust of customers with high quality and high-level development.